Riskpilot← Back to searchSign inGet full accessAPOMED AS
ASActiveOrg 924957034Grenseveien 99, 0663 OsloRetail sale of pharmaceutical products · NACE 4773Est. 202010 employees
Revenue 2024
NOK 15,2M
+169% vs 2023
EBITDA margin
-82.0%
-76% vs 2023
Equity ratio
-328.7%
Financial strength
Net profit 2024
NOK -20,9M
-173% vs 2023
| Revenue | NOK 15,2M | +169% |
| EBITDA | NOK -12,5M | -76% |
| Net profit | NOK -20,9M | -173% |
| Total assets | NOK 4,6M | -61% |
| Equity | NOK -15,2M | -370% |
| Employees | 10 | — |
Legal name
APOMED AS
Org number
924957034
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
21. april 2020
Share capital
NOK 1 002 000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Daglig leder alene.
Company purpose
Salg av apotekvarer og tilhørende varer og tjenester, samt eierskap i andre selskap, og alt som hører dertil.
Address
Grenseveien 99, 0663 Oslo
Email
info@apomed24.ru
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 716 | 5 648 | 15 198 |
| Staff expenses | −0 | −210 | −3 899 | −2 826 | −6 212 |
| EBITDA | −13 | −1 056 | −6 544 | −7 062 | −12 458 |
| Depreciation & amort. | −0 | −0 | −53 | −340 | −7 883 |
| EBIT | −13 | −1 056 | −6 597 | −7 402 | −20 341 |
| Net financials | 0 | −0 | −198 | −243 | −530 |
| Profit before tax | −13 | −1 056 | −6 795 | −7 645 | −20 871 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −13 | −1 056 | −6 795 | −7 645 | −20 871 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 12 | 5 421 | 7 571 | 11 748 | 4 631 |
| Equity | 7 | 2 214 | −2 831 | 5 646 | −15 225 |
| Long-term debt | 0 | 0 | 4 619 | 0 | 14 141 |
| Short-term debt | 4 | 3 206 | 5 783 | 6 102 | 5 715 |
| Total debt | 4 | 3 206 | 10 402 | 6 102 | 19 856 |
EBITDA margin
-82.0%
This company
15.8%
Market median
-619% vs market
20202024
Equity ratio
-328.7%
This company
38.2%
Market median
-960% vs market
20202024
Return on equity
-2087105800.0%
This company
18.4%
Market median
-11342966404% vs market
20202024
Net profit margin
-137.3%
This company
8.1%
Market median
-1795% vs market
20202024
Asset turnover
3.28×
This company
1.12×
Market median
+193% vs market
20202024
Debt / equity
1.30×
This company
0.62×
Market median
-110% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-21 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KL Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2021 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Apomed Holding As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Farmakeion As
APOMED AS Board members of APOMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kurt Leon Haga | Chief Executive Officer | 0 companies |
| Said Mustafa Rasoli | Board of Directors | 0 companies |
| Tom Georg Olsen | Board of Directors | 0 companies |
| Helge Fauskrud | Board of Directors | 0 companies |
| Einar Mathias Teigen Rasch-Halvorsen | Chairman | 0 companies |
| Thomas Andersen | Chairman | 0 companies |
| Runar Eidsaa | Board of Directors | 0 companies |
| Mads Birger Haaland-Paulsen | Board of Directors | 0 companies |